Jan C. Grutters

5.4k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Jan C. Grutters is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Jan C. Grutters has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 39 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Jan C. Grutters's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (44 papers), Sarcoidosis and Beryllium Toxicity Research (35 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Jan C. Grutters is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (44 papers), Sarcoidosis and Beryllium Toxicity Research (35 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Jan C. Grutters collaborates with scholars based in Netherlands, United States and United Kingdom. Jan C. Grutters's co-authors include Coline H.M. van Moorsel, David R. Möller, Johan Grünewald, Joachim Müller‐Quernheim, Lesley Ann Saketkoo, Elizabeth V. Arkema, Jules M.M. van den Bosch, Wim Wuyts, Athol U. Wells and Karin M. Kazemier and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Radiology.

In The Last Decade

Jan C. Grutters

57 papers receiving 2.0k citations

Hit Papers

Sarcoidosis 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Jan C. Grutters
Jan C. Grutters
Citations per year, relative to Jan C. Grutters Jan C. Grutters (= 1×) peers Rosa Metella Refini

Countries citing papers authored by Jan C. Grutters

Since Specialization
Citations

This map shows the geographic impact of Jan C. Grutters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan C. Grutters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan C. Grutters more than expected).

Fields of papers citing papers by Jan C. Grutters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan C. Grutters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan C. Grutters. The network helps show where Jan C. Grutters may publish in the future.

Co-authorship network of co-authors of Jan C. Grutters

This figure shows the co-authorship network connecting the top 25 collaborators of Jan C. Grutters. A scholar is included among the top collaborators of Jan C. Grutters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan C. Grutters. Jan C. Grutters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vogels, O.J.M., et al.. (2024). New phenotyping questionnaire for diagnosing sarcoidosis-associated small fiber neuropathy. Brain Communications. 6(5). fcae289–fcae289. 1 indexed citations
3.
Borie, Raphaël, Bruno Crestani, Liam Galvin, et al.. (2022). Genetic testing in interstitial lung disease: An international survey. Respirology. 27(9). 747–757. 10 indexed citations
4.
Savale, Laurent, Oksana A. Shlobin, Vasileios Kouranos, et al.. (2022). WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. European Respiratory Review. 31(163). 210165–210165. 35 indexed citations
5.
Bakker, Annelies L.M., et al.. (2020). Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series.. PubMed Central. 37(1). 74–78. 12 indexed citations
6.
Moor, Catharina C., Rémy L.M. Mostard, Jan C. Grutters, et al.. (2020). Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 202(3). 393–401. 83 indexed citations
7.
Vogels, O.J.M., et al.. (2020). Current View of Diagnosing Small Fiber Neuropathy. Journal of Neuromuscular Diseases. 8(2). 185–207. 38 indexed citations
8.
Baughman, Robert P., Marc A. Judson, Jennifer L. Beaumont, et al.. (2020). Evaluating the Minimal Clinically Important Difference of the King’s Sarcoidosis Questionnaire in a Multicenter Prospective Study. Annals of the American Thoracic Society. 18(3). 477–485. 19 indexed citations
9.
Bakker, Annelies L.M., Johannes J. Mager, Repke J. Snijder, et al.. (2020). Predicting pulmonary hypertension in sarcoidosis; value of PH probability on echocardiography. International journal of cardiac imaging. 36(8). 1497–1505. 7 indexed citations
10.
Nat, P. B. van der, Lea M. Dijksman, Frouke T. van Beek, et al.. (2019). Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes. ERJ Open Research. 5(4). 94–2019. 8 indexed citations
11.
Vancheri, Carlo, Michael Kreuter, Luca Richeldi, et al.. (2017). Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial. American Journal of Respiratory and Critical Care Medicine. 197(3). 356–363. 208 indexed citations
12.
Manen, Mirjam J.G. van, et al.. (2017). Clubbing in patients with fibrotic interstitial lung diseases. Respiratory Medicine. 132. 226–231. 16 indexed citations
13.
Wuyts, Wim, Κατερίνα Αντωνίου, Keren Borensztajn, et al.. (2014). Combination therapy: the future of management for idiopathic pulmonary fibrosis?. The Lancet Respiratory Medicine. 2(11). 933–942. 115 indexed citations
14.
Korthagen, N.M., Coline H.M. van Moorsel, Karin M. Kazemier, Henk J.T. Ruven, & Jan C. Grutters. (2012). IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study. Immunogenetics. 64(5). 371–377. 50 indexed citations
15.
Korthagen, N.M., Coline H.M. van Moorsel, Nicole P. Barlo, et al.. (2012). Association between Variations in Cell Cycle Genes and Idiopathic Pulmonary Fibrosis. PLoS ONE. 7(1). e30442–e30442. 42 indexed citations
16.
Grutters, Jan C., et al.. (2011). Post-inflammatory fatigue in sarcoidosis: Personality profiles, psychological symptoms and stress hormones. Journal of Psychosomatic Research. 72(2). 97–102. 21 indexed citations
17.
Spagnolo, Paolo, Elisabetta Renzoni, Athol U. Wells, et al.. (2005). C-C Chemokine Receptor 5 Gene Variants in Relation to Lung Disease in Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 172(6). 721–728. 48 indexed citations
18.
Grutters, Jan C. & R M du Bois. (2005). Genetics of fibrosing lung diseases. European Respiratory Journal. 25(5). 915–927. 70 indexed citations
19.
Spagnolo, Paolo, Elisabetta Renzoni, Athol U. Wells, et al.. (2003). C-C Chemokine Receptor 2 and Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 168(10). 1162–1166. 81 indexed citations
20.
Grutters, Jan C., et al.. (2001). Patent foramen ovale causing position-dependent shunting in a patient, when laying down her corset. European Respiratory Journal. 18(4). 731–733. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026